REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 6th, 2024 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Agreement is made pursuant to the Investment Agreement, dated as of March 4, 2024, between the Company and the Investors (as amended, amended and restated or otherwise modified from time to time, the “Investment Agreement”), pursuant to which the Company is selling to the Investors, and the Investors are purchasing from the Company, in each case on the Closing Date (as defined in the Investment Agreement), an aggregate of 92,009,981 shares (the “Shares”) of common stock, $0.001 par value of the Company (the “Common Stock”).
INVESTMENT AGREEMENTInvestment Agreement • March 6th, 2024 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This Investment Agreement (this “Agreement”), dated as of March 4, 2024, by and among Perspective Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business at 2401 Elliott Avenue, Suite 320, Seattle, Washington 98121 and each purchaser identified on Schedule 1 hereto (each, an “Investor” and collectively, the “Investors”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.5.
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 6th, 2024 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
Introduction. Subject to the terms and conditions herein (this “Agreement”), Perspective Therapeutics, Inc., a Delaware corporation (the “Company”), hereby agrees to issue and sell directly to various investors (each, an “Investor” and, collectively, the “Investors”) through the several placement agents named in Schedule A hereto (collectively, the “Placement Agents”), pursuant to the terms and conditions of this Placement Agency Agreement (this “Agreement”) and the Investment Agreement in the form of Exhibit A attached hereto (the “Investment Agreement”) entered into with such Investors, 92,009,981 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) (the Shares being referred to as, the “Securities”). The Company hereby confirms its agreement with the Placement Agents in accordance with the terms and conditions hereof. The Placement Agents may retain other brokers or dealers to act as sub-agents or selected-dealers on their behalf in co
